ORIENT BIO Inc. (KRX:002630)

Revenue by Product

Financials in millions KRW. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	Mar 31, 2003
Biomaterials	20.16B
Biomaterials Growth	-5.02%
Biological Materials, Etc	9.24B
Biological Materials, Etc Growth	36.28%

Revenue by Geography

Financials in millions KRW. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004	Mar 31, 2003
South Korea	29.17B
South Korea Growth	4.48%
International	227.26M
International Growth	162.98%